Securing a significant Atopic Dermatitis Market Share requires a combination of clinical excellence, strategic marketing, and robust patient support programs. Currently, the market is led by a handful of first-mover companies that have established strong brand recognition and deep relationships with dermatological associations. However, the landscape is becoming increasingly crowded as new entrants bring "me-too" biologics and novel small molecules to market. To maintain their dominance,...